Nyxoah S A (NYXH)

$10.91 0.00 (N/A)
Market Cap 272.10M
Revenue (ttm) 4.71M
Net Income (ttm) -46.77M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -992.99%
Debt to Equity Ratio 0.19
Volume 104,500
Avg Vol 48,836
Day's Range N/A - N/A
Shares Out 24.94M
Stochastic %K 81%
Beta 1.35
Analysts Strong Sell
Price Target $14.83

Latest News on NYXH

Publication relating to transparency notifications

Jan 20, 2025, 4:30 PM EST - 13 hours ago

Publication relating to transparency notifications

Nyxoah: The Future Of OSA

Dec 30, 2024, 4:01 AM EST - 22 days ago

Nyxoah: The Future Of OSA

Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England

Dec 13, 2024, 2:05 AM EST - 5 weeks ago

Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 20, 2024, 4:05 PM EST - 2 months ago

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference

Invitation to attend the special shareholders' meeting of the Company to be held on December 19, 2024

Nov 19, 2024, 1:00 AM EST - 2 months ago

Invitation to attend the special shareholders' meeting of the Company to be held on December 19, 2024

Nyxoah S.A. (NYXH) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 6:46 PM EST - 2 months ago

Nyxoah S.A. (NYXH) Q3 2024 Earnings Call Transcript

Nyxoah Appoints John Landry as Chief Financial Officer

Nov 4, 2024, 4:45 PM EST - 2 months ago

Nyxoah Appoints John Landry as Chief Financial Officer

Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024

Oct 22, 2024, 4:30 PM EDT - 3 months ago

Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024

Nyxoah Raises $27 Million through its At-the-Market Offering

Oct 7, 2024, 5:00 PM EDT - 3 months ago

Nyxoah Raises $27 Million through its At-the-Market Offering

DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update

Sep 27, 2024, 4:30 PM EDT - 4 months ago

DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update

Nyxoah to Participate in Upcoming Investor Conferences

Sep 5, 2024, 4:30 PM EDT - 4 months ago

Nyxoah to Participate in Upcoming Investor Conferences

Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device

Sep 2, 2024, 4:05 PM EDT - 5 months ago

Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device

Nyxoah S.A. (NYXH) Q2 2024 Earnings Call Transcript

Aug 11, 2024, 1:44 AM EDT - 5 months ago

Nyxoah S.A. (NYXH) Q2 2024 Earnings Call Transcript

Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results

Aug 6, 2024, 4:05 PM EDT - 5 months ago

Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results

Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024

Jul 29, 2024, 4:30 PM EDT - 6 months ago

Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024

Nyxoah Appoints Scott Holstine as Chief Commercial Officer

Jul 15, 2024, 2:00 AM EDT - 6 months ago

Nyxoah Appoints Scott Holstine as Chief Commercial Officer

Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank

Jul 3, 2024, 6:30 AM EDT - 7 months ago

Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank

Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA

Jul 1, 2024, 2:00 AM EDT - 7 months ago

Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA

Nyxoah to Participate in the Jefferies Global Healthcare Conference

Jun 3, 2024, 4:30 PM EDT - 8 months ago

Nyxoah to Participate in the Jefferies Global Healthcare Conference

Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares

May 31, 2024, 2:00 AM EDT - 8 months ago

Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares

Nyxoah Announces Pricing of Offering

May 23, 2024, 9:59 AM EDT - 8 months ago

Nyxoah Announces Pricing of Offering

Nyxoah Announces Reduction of the Maximum Amount Available Under its At the-Market Equity Offering Program

May 22, 2024, 4:10 PM EDT - 8 months ago

Nyxoah Announces Reduction of the Maximum Amount Available Under its At the-Market Equity Offering Program

Nyxoah Announces Proposed Offering of Ordinary Shares

May 22, 2024, 4:05 PM EDT - 8 months ago

Nyxoah Announces Proposed Offering of Ordinary Shares

Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024

May 13, 2024, 4:30 PM EDT - 9 months ago

Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024

Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 12, 2024

May 10, 2024, 1:00 AM EDT - 9 months ago

Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 12, 2024

Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer

Apr 11, 2024, 4:30 PM EDT - 10 months ago

Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer

Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation

Mar 25, 2024, 2:05 AM EDT - 10 months ago

Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation

Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints

Mar 19, 2024, 4:05 PM EDT - 10 months ago

Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints

Nyxoah S.A. (NYXH) Q4 2023 Earnings Call Transcript

Mar 5, 2024, 6:49 PM EST - 11 months ago

Nyxoah S.A. (NYXH) Q4 2023 Earnings Call Transcript

Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results

Mar 5, 2024, 4:05 PM EST - 11 months ago

Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results

Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Feb 29, 2024, 4:30 PM EST - 11 months ago

Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024

Feb 15, 2024, 4:30 PM EST - 1 year ago

Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024

Nyxoah Announces 2024 Strategic Priorities

Jan 17, 2024, 4:05 PM EST - 1 year ago

Nyxoah Announces 2024 Strategic Priorities

Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2023

Jan 9, 2024, 4:05 PM EST - 1 year ago

Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2023

Nyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio®

Dec 11, 2023, 1:30 AM EST - 1 year ago

Nyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio®

Publication Relating to a Transparency Notification

Dec 8, 2023, 4:30 PM EST - 1 year ago

Publication Relating to a Transparency Notification

Nyxoah Strengthens its Executive Leadership Team

Nov 28, 2023, 4:30 PM EST - 1 year ago

Nyxoah Strengthens its Executive Leadership Team

Nyxoah to Participate in the Piper Sandler 35th Annual Healthcare Conference

Nov 21, 2023, 4:30 PM EST - 1 year ago

Nyxoah to Participate in the Piper Sandler 35th Annual Healthcare Conference

Nyxoah S.A. (NYXH) Q3 2023 Earnings Call Transcript

Nov 11, 2023, 1:28 PM EST - 1 year ago

Nyxoah S.A. (NYXH) Q3 2023 Earnings Call Transcript

Nyxoah Reports Third Quarter 2023 Financial and Operating Results

Nov 8, 2023, 4:05 PM EST - 1 year ago

Nyxoah Reports Third Quarter 2023 Financial and Operating Results

Nyxoah to Participate in the Jefferies London Healthcare Conference

Nov 7, 2023, 4:30 PM EST - 1 year ago

Nyxoah to Participate in the Jefferies London Healthcare Conference

Nyxoah to Release Third Quarter 2023 Financial Results on November 8, 2023

Oct 26, 2023, 4:30 PM EDT - 1 year ago

Nyxoah to Release Third Quarter 2023 Financial Results on November 8, 2023

Nyxoah Announces Partnership with ResMed in Germany

Sep 28, 2023, 4:30 PM EDT - 1 year ago

Nyxoah Announces Partnership with ResMed in Germany

Nyxoah to Participate in the Cantor Fitzgerald Global Healthcare Conference

Sep 12, 2023, 4:30 PM EDT - 1 year ago

Nyxoah to Participate in the Cantor Fitzgerald Global Healthcare Conference

Nyxoah S.A. (NYXH) Q2 2023 Earnings Call Transcript

Aug 11, 2023, 10:10 AM EDT - 1 year ago

Nyxoah S.A. (NYXH) Q2 2023 Earnings Call Transcript

Nyxoah Reports Second Quarter and First Half 2023 Financial and Operating Results

Aug 8, 2023, 4:05 PM EDT - 1 year ago

Nyxoah Reports Second Quarter and First Half 2023 Financial and Operating Results

Nyxoah to Release Second Quarter 2023 Financial Results on August 8, 2023

Jul 27, 2023, 4:30 PM EDT - 1 year ago

Nyxoah to Release Second Quarter 2023 Financial Results on August 8, 2023

Nyxoah to Participate in the 43rd Canaccord Genuity Growth Conference

Jul 27, 2023, 4:30 PM EDT - 1 year ago

Nyxoah to Participate in the 43rd Canaccord Genuity Growth Conference

Nyxoah S.A. (NYXH) Q1 2023 Earnings Call Transcript

May 16, 2023, 8:34 PM EDT - 1 year ago

Nyxoah S.A. (NYXH) Q1 2023 Earnings Call Transcript

Nyxoah Reports First Quarter 2023 Financial and Operating Results

May 16, 2023, 4:05 PM EDT - 1 year ago

Nyxoah Reports First Quarter 2023 Financial and Operating Results